Researchers are currently developing a new vaccine to treat cytomegalovirus (CMV) infection, which is the leading infectious cause of congenital birth defects, affecting one in every 750 children born who develop permanent disabilities such as brain damage or hearing loss. Researchers from the La Jolla Institute for Allergy (and) Immunology and Cardiff University in Wales (UK) have discovered a previously unknown cellular mechanism that could prove critical in creating ...
View the Original article
